Prolyl oligopeptidase inhibition reduces PolyQ aggregation and improves cell viability in cellular model of Huntington’s disease

Схожие документы

• Removal of prolyl oligopeptidase reduces alpha-synuclein toxicity in cells and in vivo
  по: Svarcbahs, Reinis, et al.
  Опубликовано: (2018)
• Molecular and structural architecture of polyQ aggregates in yeast
  по: Gruber, Anselm, et al.
  Опубликовано: (2018)
• Effects of Q/N-rich, polyQ, and non-polyQ amyloids on the de novo formation of the [PSI(+)] prion in yeast and aggregation of Sup35 in vitro
  по: Derkatch, Irina L., et al.
  Опубликовано: (2004)
• Distribution of Prolyl Oligopeptidase in Human Peripheral Tissues and in Ovarian and Colorectal Tumors
  по: Myöhänen, Timo T., et al.
  Опубликовано: (2012)
• Ataxin-1 Fusion Partners Alter PolyQ Lethality and Aggregation
  по: Rich, Tina, et al.
  Опубликовано: (2007)